Status:
COMPLETED
Women's Health Communication Study
Lead Sponsor:
Fox Chase Cancer Center
Conditions:
Gynecologic Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The central goal of this randomized, controlled pilot study is to examine the feasibility, acceptability, and preliminary effects of an educational intervention (called "Starting the Conversation"; ST...
Eligibility Criteria
Inclusion
- Diagnosis of any stage (I-IV) gynecologic cancer (uterine, ovarian, cervical, vaginal/vulvar, fallopian tube, peritoneal)
- Receiving any treatment for gynecologic cancer or have completed acute treatment \< 10 years ago
- Attending clinic visits in the course of follow-up care (i.e., not an initial consult visit)
Exclusion
- Not able to speak English
- Eastern Cooperative Oncology Group (ECOG) Performance status score \> 2
- Overt cognitive dysfunction or psychiatric disturbance or severe mental illness (e.g., dementia, suicidal behavior, or psychosis), as observed or judged by the researcher or referring source.
Key Trial Info
Start Date :
February 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05359952
Start Date
February 9 2022
End Date
August 22 2022
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111